The Effect of Sunitinib on Immune Subsets in Metastatic Clear Cell Renal Cancer

Publisher： Karger

E-ISSN： 1423-0399|86|1|53-59

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.86, Iss.1, 2010-10, pp. : 53-59

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Relationships between the Effect of Sunitinib and Immature Blood Vessels in Metastatic Renal Cell Cancer

By  

Urologia Internationalis, Vol. 94, Iss. 2, 2015-0 ,pp. : 137-143

Karger

Access to resources Recommend Favorite

Continuous Daily Dosing of Sunitinib in Patients with Metastatic Renal Cell Cancer

By  

Oncology Research and Treatment, Vol. 31, Iss. 8-9, 2008-08 ,pp. : 432-433

Karger

Access to resources Recommend Favorite

Safety and efficacy of sunitinib for advanced non‐clear cell renal cell carcinoma

By  

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 11, Iss. 4, 2015-12 ,pp. : 328-333

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Pooled Analysis of Sequential Therapies with Sorafenib and Sunitinib in Metastatic Renal Cell Carcinoma

By  

Oncology, Vol. 82, Iss. 6, 2012-06 ,pp. : 333-340

Karger

Access to resources Recommend Favorite

Continuous Therapy with Sunitinib in Patients with Metastatic Renal Cell Carcinoma

By  

Oncology Research and Treatment, Vol. 31, Iss. 8-9, 2008-07 ,pp. : 485-485

Karger

Access to resources Recommend Favorite